PROCEPT BioRobotics (PRCT) Cash from Investing Activities (2020 - 2026)
PROCEPT BioRobotics (PRCT) reported Cash from Investing Activities of -$2.9 million for Q1 2026, down 58.71% year-over-year from -$7.1 million in Q1 2025, and down 57.51% on a QoQ basis from -$1.8 million in Q4 2025.
PROCEPT BioRobotics (PRCT) has 7 years of Cash from Investing Activities data on file, last reported at -$2.9 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 58.71% year-over-year to -$2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.4 million (down 142.71% YoY) and the FY2025 annual result came in at -$9.4 million, down 112.2% from the prior year.
- Cash from Investing Activities fell to -$2.9 million in Q1 2026 per PRCT's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$55000.0 in Q1 2022 and bottomed at -$8.7 million in Q4 2023.
- The 5-year median for Cash from Investing Activities is -$1.8 million (2025), against an average of -$2.6 million.
- The widest annual swing landed in 2023, when Cash from Investing Activities sank 9607.27%; it then surged 95.74% in 2024.
- Tracing PRCT's Cash from Investing Activities over 5 years: stood at -$866000.0 in 2022, then tumbled by 906.35% to -$8.7 million in 2023, then surged by 86.53% to -$1.2 million in 2024, then plunged by 57.58% to -$1.8 million in 2025, then plunged by 57.51% to -$2.9 million in 2026.
- Per Business Quant, the three latest PRCT Cash from Investing Activities figures stand at -$2.9 million (Q1 2026), -$1.8 million (Q4 2025), and -$2.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | PROCEPT BioRobotics | 1.58 Bn | 1.33 Bn | 53.95 Mn | -2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.91 Mn |
| Mar 31, 2026 | -2.91 Mn |
| Dec 31, 2025 | -1.85 Mn |
| Dec 31, 2025 | -1.85 Mn |
| Sep 30, 2025 | -2.87 Mn |
| Sep 30, 2025 | -2.87 Mn |
| Jun 30, 2025 | -2.80 Mn |
| Jun 30, 2025 | -2.80 Mn |
| Mar 31, 2025 | -1.84 Mn |
| Mar 31, 2025 | -1.84 Mn |
| Dec 31, 2024 | -1.17 Mn |
| Dec 31, 2024 | -1.17 Mn |
| Sep 30, 2024 | -246,000.00 |
| Sep 30, 2024 | -246,000.00 |
| Jun 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | -1.04 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Dec 31, 2023 | -8.72 Mn |
| Dec 31, 2023 | -8.72 Mn |
| Sep 30, 2023 | -5.78 Mn |
| Sep 30, 2023 | -5.78 Mn |
| Jun 30, 2023 | -5.37 Mn |
| Jun 30, 2023 | -5.37 Mn |
| Mar 31, 2023 | -5.34 Mn |
| Mar 31, 2023 | -5.34 Mn |
| Dec 31, 2022 | -866,000.00 |
| Dec 31, 2022 | -866,000.00 |
| Sep 30, 2022 | -1.51 Mn |
| Sep 30, 2022 | -1.51 Mn |
| Jun 30, 2022 | -218,000.00 |
| Jun 30, 2022 | -218,000.00 |
| Mar 31, 2022 | -55,000.00 |
| Mar 31, 2022 | -55,000.00 |
| Dec 31, 2021 | -332,000.00 |
| Dec 31, 2021 | -332,000.00 |
| Sep 30, 2021 | -111,000.00 |
| Sep 30, 2021 | -111,000.00 |
| Jun 30, 2021 | -110,000.00 |
| Jun 30, 2021 | -110,000.00 |
| Mar 31, 2021 | -39,000.00 |
| Mar 31, 2021 | -39,000.00 |
| Dec 31, 2020 | -9,000.00 |
| Dec 31, 2020 | -9,000.00 |